#USA #Los Angeles #Primary Immunodeficiency #Jeffrey Modell Foundation #Donald B. Kohn

Exciting Virtual Talk on Gene Therapy

On March 25, 2026, the Jeffrey Modell Foundation (JMF) is set to host a significant virtual event featuring Dr. Donald B. Kohn, a Distinguished Professor at UCLA. This talk aims to illuminate the vital role of gene therapy in treating Primary Immunodeficiency (PI) and Inborn Errors of Immunity.

About the Event

In its quest to enhance awareness and understanding of PI, the JMF has initiated the JMF Speaker Series, a global educational program aimed at connecting various stakeholders like clinicians, researchers, and advocates. From last year onward, this initiative has been instrumental in fostering innovation while significantly improving outcomes for those affected by Primary Immunodeficiency. Vanessa Tenembaum, CEO of the JMF, expressed enthusiasm about having Dr. Kohn share his expertise during this event: “His insights will be invaluable in transforming the lives of individuals living with PI.”

The session will be moderated by Dr. Jordan S. Orange, a leading pediatric immunologist and the Chair of the Department of Pediatrics at Children's Hospital of Philadelphia. The format will encourage interactive discussions, ensuring participants can engage directly with Dr. Kohn during the session.

Dr. Donald B. Kohn - A Leading Voice in Gene Therapy

Dr. Kohn's work is pivotal in the realm of gene therapy, particularly concerning blood cell diseases related to Primary Immunodeficiency and other genetic disorders. He has dedicated his career to improving therapeutic techniques for editing genes in hematopoietic stem cells, focusing on developing cutting-edge treatments that could one day cure these longstanding conditions. His laboratory and clinical studies are at the forefront of emerging therapies, aiming to provide hope to patients worldwide battling these immune deficiencies.

For many living with Primary Immunodeficiency, timely diagnosis and effective treatment options have historically been limited. Dr. Kohn's ongoing research addresses these challenges head-on, giving rise to new possibilities for patient care by exploring innovative methodologies in gene therapy.

Register for the Event

Participation in this insightful talk is free and open to all around the globe. Those interested can register via the Jeffrey Modell Foundation's website for a chance to gain insights into the latest advancements in gene therapy and how they can affect patient care significantly. More information can be found by visiting the JMF Speaker Series page online.

This event aligns with the objectives set forth by the Accreditation Council for Continuing Medical Education (ACCME), ensuring that it meets the highest standards in medical education initiatives. The collaboration between the JMF and The Columbia University Vagelos College of Physicians and Surgeons contributes to a comprehensive educational experience for all participants.

About the Jeffrey Modell Foundation

Founded in 1987 by Fred and the late Vicki Modell, the Jeffrey Modell Foundation serves as a beacon of hope for those afflicted with Primary Immunodeficiency. Their efforts aim to enhance early diagnosis and promote research initiatives that lead to effective treatments and potential cures. The foundation is committed to increasing public awareness and providing invaluable support to families navigating this challenging condition.

Mark your calendars for March 25, and don’t miss this opportunity to learn from one of the foremost experts in the field of gene therapy, helping pave the way for better health outcomes in the world of Immunology.